However, studies on prostate cancer indicated a discordant oncogenic role and different molecular mechanisms underlying SOCS2-AS1 action20, thereby suggesting tissue-specific regulation of SOCS2-AS1 expression. The gene discussed is SOCS2; the disease is prostate cancer.